Abstract
This is a summary article of a noteworthy publication that has reclassified nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) to metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH), respectively. A new term, MASLD with increased alcohol intake (MetALD), has been proposed to classify patients previously classified as having NAFLD with excess alcohol intake. This article is designed to draw the reader’s attention to the changes in nomenclature in liver disease. This is pertinent in dermatology as many patients copresent with MASLD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
